Skip to main content

Advertisement

Table 2 Summary of PRMT5 scoring distribution

From: Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin

Composite score Normal liver tissue (n = 54) HCC tissue (n = 54)
<2 (weak immunopositivity) 28 (51.9 %) 5 (9.3 %)
2–4 (moderate immunopositivity) 22 (40.7 %) 18 (33.3 %)
≥4 (strong immunopositivity) 4 (7.4 %) 31 (57.4 %)
P values   <0.0001
  1. P value calculated by χ 2 test for normal liver tissue versus HCC tissue